SSX2 and soft tissue sarcoma: In this study, we analysed the expression of CTAs PRAME, NY-ESO-1, and SSX2 as well as the presence of tumour-infiltrating lymphocytes (TILs) in a well-characterised cohort of high-grade soft tissue sarcoma patients.